220 related articles for article (PubMed ID: 27683263)
1. SMAD3 Activation: A Converging Point of Dysregulated TGF-Beta Superfamily Signaling and Genetic Aberrations in Granulosa Cell Tumor Development?
Fang X; Gao Y; Li Q
Biol Reprod; 2016 Nov; 95(5):105. PubMed ID: 27683263
[TBL] [Abstract][Full Text] [Related]
2. FOXL2, GATA4, and SMAD3 co-operatively modulate gene expression, cell viability and apoptosis in ovarian granulosa cell tumor cells.
Anttonen M; Pihlajoki M; Andersson N; Georges A; L'hôte D; Vattulainen S; Färkkilä A; Unkila-Kallio L; Veitia RA; Heikinheimo M
PLoS One; 2014; 9(1):e85545. PubMed ID: 24416423
[TBL] [Abstract][Full Text] [Related]
3. Disruption of postnatal folliculogenesis and development of ovarian tumor in a mouse model with aberrant transforming growth factor beta signaling.
Gao Y; Fang X; Vincent DF; Threadgill DW; Bartholin L; Li Q
Reprod Biol Endocrinol; 2017 Dec; 15(1):94. PubMed ID: 29221447
[TBL] [Abstract][Full Text] [Related]
4. The transcriptional targets of mutant FOXL2 in granulosa cell tumours.
Rosario R; Araki H; Print CG; Shelling AN
PLoS One; 2012; 7(9):e46270. PubMed ID: 23029457
[TBL] [Abstract][Full Text] [Related]
5. The molecular mechanism of ovarian granulosa cell tumors.
Li J; Bao R; Peng S; Zhang C
J Ovarian Res; 2018 Feb; 11(1):13. PubMed ID: 29409506
[TBL] [Abstract][Full Text] [Related]
6. Smad1-Smad5 ovarian conditional knockout mice develop a disease profile similar to the juvenile form of human granulosa cell tumors.
Middlebrook BS; Eldin K; Li X; Shivasankaran S; Pangas SA
Endocrinology; 2009 Dec; 150(12):5208-17. PubMed ID: 19819941
[TBL] [Abstract][Full Text] [Related]
7. A novel mouse model of testicular granulosa cell tumors.
Fang X; Ni N; Gao Y; Vincent DF; Bartholin L; Li Q
Mol Hum Reprod; 2018 Jul; 24(7):343-356. PubMed ID: 29788434
[TBL] [Abstract][Full Text] [Related]
8. FOXO1/3 and PTEN Depletion in Granulosa Cells Promotes Ovarian Granulosa Cell Tumor Development.
Liu Z; Ren YA; Pangas SA; Adams J; Zhou W; Castrillon DH; Wilhelm D; Richards JS
Mol Endocrinol; 2015 Jul; 29(7):1006-24. PubMed ID: 26061565
[TBL] [Abstract][Full Text] [Related]
9. Mutation of FOXL2 in granulosa-cell tumors of the ovary.
Shah SP; Köbel M; Senz J; Morin RD; Clarke BA; Wiegand KC; Leung G; Zayed A; Mehl E; Kalloger SE; Sun M; Giuliany R; Yorida E; Jones S; Varhol R; Swenerton KD; Miller D; Clement PB; Crane C; Madore J; Provencher D; Leung P; DeFazio A; Khattra J; Turashvili G; Zhao Y; Zeng T; Glover JN; Vanderhyden B; Zhao C; Parkinson CA; Jimenez-Linan M; Bowtell DD; Mes-Masson AM; Brenton JD; Aparicio SA; Boyd N; Hirst M; Gilks CB; Marra M; Huntsman DG
N Engl J Med; 2009 Jun; 360(26):2719-29. PubMed ID: 19516027
[TBL] [Abstract][Full Text] [Related]
10. Aberrant granulosa cell-fate related to inactivated p53/Rb signaling contributes to granulosa cell tumors and to FOXL2 downregulation in the mouse ovary.
Cluzet V; Devillers MM; Petit F; Chauvin S; François CM; Giton F; Genestie C; di Clemente N; Cohen-Tannoudji J; Guigon CJ
Oncogene; 2020 Feb; 39(9):1875-1890. PubMed ID: 31745296
[TBL] [Abstract][Full Text] [Related]
11. Misregulated Wnt/beta-catenin signaling leads to ovarian granulosa cell tumor development.
Boerboom D; Paquet M; Hsieh M; Liu J; Jamin SP; Behringer RR; Sirois J; Taketo MM; Richards JS
Cancer Res; 2005 Oct; 65(20):9206-15. PubMed ID: 16230381
[TBL] [Abstract][Full Text] [Related]
12. The role of FOXL2 in the pathogenesis of adult ovarian granulosa cell tumours.
Rosario R; Cohen PA; Shelling AN
Gynecol Oncol; 2014 May; 133(2):382-7. PubMed ID: 24342437
[TBL] [Abstract][Full Text] [Related]
13. Nuclear receptor profiling of ovarian granulosa cell tumors.
Alexiadis M; Eriksson N; Jamieson S; Davis M; Drummond AE; Chu S; Clyne CD; Muscat GE; Fuller PJ
Horm Cancer; 2011 Jun; 2(3):157-69. PubMed ID: 21761343
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of FOXL2 codon 134 in granulosa cell tumour of ovary and other human cancers.
Kim MS; Hur SY; Yoo NJ; Lee SH
J Pathol; 2010 Jun; 221(2):147-52. PubMed ID: 20198651
[TBL] [Abstract][Full Text] [Related]
15. Impact of FOXL2 mutations on signaling in ovarian granulosa cell tumors.
Leung DTH; Fuller PJ; Chu S
Int J Biochem Cell Biol; 2016 Mar; 72():51-54. PubMed ID: 26791928
[TBL] [Abstract][Full Text] [Related]
16. Adult granulosa cell tumours (GCT): clinicopathological outcomes including FOXL2 mutational status and expression.
Rosario R; Wilson M; Cheng WT; Payne K; Cohen PA; Fong P; Shelling AN
Gynecol Oncol; 2013 Nov; 131(2):325-9. PubMed ID: 24007948
[TBL] [Abstract][Full Text] [Related]
17. A cellular model provides insights into the pathogenicity of the oncogenic FOXL2 somatic variant p.Cys134Trp.
Herman L; Amo A; Legois B; Di Carlo C; Veitia RA; Todeschini AL
Br J Cancer; 2024 May; 130(9):1453-1462. PubMed ID: 38429437
[TBL] [Abstract][Full Text] [Related]
18. Adenoviral gene transfer allows Smad-responsive gene promoter analyses and delineation of type I receptor usage of transforming growth factor-beta family ligands in cultured human granulosa luteal cells.
Kaivo-Oja N; Mottershead DG; Mazerbourg S; Myllymaa S; Duprat S; Gilchrist RB; Groome NP; Hsueh AJ; Ritvos O
J Clin Endocrinol Metab; 2005 Jan; 90(1):271-8. PubMed ID: 15483083
[TBL] [Abstract][Full Text] [Related]
19. High GATA-4 expression associates with aggressive behavior, whereas low anti-Müllerian hormone expression associates with growth potential of ovarian granulosa cell tumors.
Anttonen M; Unkila-Kallio L; Leminen A; Butzow R; Heikinheimo M
J Clin Endocrinol Metab; 2005 Dec; 90(12):6529-35. PubMed ID: 16159935
[TBL] [Abstract][Full Text] [Related]
20. FOXO1 mitigates the SMAD3/FOXL2
Secchi C; Benaglio P; Mulas F; Belli M; Stupack D; Shimasaki S
J Transl Med; 2021 Feb; 19(1):90. PubMed ID: 33639972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
